| 000 | 01396 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512083131.0 | ||
| 264 | 0 | _c19850624 | |
| 008 | 198506s 0 0 eng d | ||
| 022 | _a0732-6580 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchulof, R S | |
| 245 | 0 | 0 |
_aA randomized trial to evaluate the immunorestorative properties of synthetic thymosin-alpha 1 in patients with lung cancer. _h[electronic resource] |
| 260 |
_bJournal of biological response modifiers _cApr 1985 |
||
| 300 |
_a147-58 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdjuvants, Immunologic |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunity, Cellular _xdrug effects |
| 650 | 0 | 4 | _aImmunosuppression Therapy |
| 650 | 0 | 4 |
_aLung Neoplasms _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRadiation Injuries |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aThymalfasin |
| 650 | 0 | 4 |
_aThymosin _xanalogs & derivatives |
| 700 | 1 | _aLloyd, M J | |
| 700 | 1 | _aCleary, P A | |
| 700 | 1 | _aPalaszynski, S R | |
| 700 | 1 | _aMai, D A | |
| 700 | 1 | _aCox, J W | |
| 700 | 1 | _aAlabaster, O | |
| 700 | 1 | _aGoldstein, A L | |
| 773 | 0 |
_tJournal of biological response modifiers _gvol. 4 _gno. 2 _gp. 147-58 |
|
| 999 |
_c4004450 _d4004450 |
||